A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis (MS) in Finland between 2013 and 2022. According to the study published in ...

A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave University of Michigan researchers a first ...

During MS Awareness Month, a Groundbreaking Research-and-Care Model Looks Back on 20 Years of Firsts I am eager to see ...

To provide the right treatment for multiple sclerosis (MS), it is important to know when the disease changes from relapsing-remitting to secondary progressive, a transition that is currently ...

Secondary progressive multiple sclerosis (SPMS) can develop after relapsing-remitting multiple sclerosis (RRMS). It causes steady neurological decline, either with or without relapses. Switching from ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. This enduring CE multimedia web activity is based on a ...

In a study of commonly used treatments for people with multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in meaningful improvements in fatigue, a ...

Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease that affects 3 million people worldwide.

March is Multiple Sclerosis Awareness Month, a time dedicated to raising awareness about a neurological condition that ...

Multiple Sclerosis Awareness Month is a time to recognize those affected by the disease and the treatments available to ...

Roche India with Punjab Government unveils ‘NeuroSakhi’, state-level initiative to strengthen multiple sclerosis care: Our Bureau, Bengaluru Thursday, March 12, 2026, 14:15 Hr ...